Abstract
Asthma treatment remains challenging, especially in low-resource settings, as it revolves around inhaler devices. The inhalers are too expensive to buy from a pharmacy and not available from a public health facility. Besides, one-to-one training is required for the correct use of inhalers. Therefore, this therapy is associated with low adherence. Improper training leads to faulty use, inadequate treatment, and drug wastage. Asthma is an inflammatory condition that requires a bronchodilator for relief during acute exacerbation and an anti-inflammatory agent for prevention. The use of oral salbutamol, in place of inhaled beta-agonists, and oral slow-release theophylline in place of inhaled corticosteroids offers a feasible option. This may make the treatment easier to deliver and more affordable in low-resource settings.